ProCE Banner Activity

CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions

Podcast Episodes
Listen to Michael R. Bishop, MD; Daniel J. DeAngelo, MD, PhD; and Noopur Raje, MD, answer audience questions from a series of live CCO Webinars focused on current best practices and emerging applications with CAR T-cell therapy.

Released: September 14, 2020

Expiration: September 13, 2021

Share

Faculty

Michael R. Bishop

Michael R. Bishop, MD

Professor of Medicine, Director
Section of Hematology/Oncology,
Cellular Therapy Program
University of Chicago
Chicago, Illinois

Daniel J. DeAngelo

Daniel J. DeAngelo, MD, PhD

Professor of Medicine
Harvard Medical School
Chief, Division of Leukemia
Dana-Farber Cancer Institute
Boston, Massachusetts

Noopur Raje

Noopur Raje, MD

Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Celgene

Legend Biotech USA Inc.

Program Director Disclosure

Program Director

Michael R. Bishop, MD

Professor of Medicine, Director
Section of Hematology/Oncology,
Cellular Therapy Program
University of Chicago
Chicago, Illinois

Faculty Disclosure

Primary Author

Daniel J. DeAngelo, MD, PhD

Professor of Medicine
Harvard Medical School
Chief, Division of Leukemia
Dana-Farber Cancer Institute
Boston, Massachusetts

Noopur Raje, MD

Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Staff Disclosure

Staff

Jason J. Everly, PharmD

Kevin Obholz, PhD

Editorial Director, Hematology/Oncology

Timothy A. Quill, PhD

Senior Managing Editor

Ryan P. Topping, PhD

Associate Managing Editor

June Wasserstrom,

Director, CME Program Development